1. Home
  2. HUBB vs RMD Comparison

HUBB vs RMD Comparison

Compare HUBB & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hubbell Inc

HUBB

Hubbell Inc

HOLD

Current Price

$474.03

Market Cap

25.4B

Sector

Technology

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$215.79

Market Cap

28.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBB
RMD
Founded
1888
1989
Country
United States
United States
Employees
N/A
10600
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.4B
28.4B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
HUBB
RMD
Price
$474.03
$215.79
Analyst Decision
Buy
Buy
Analyst Count
8
10
Target Price
$517.88
$292.56
AVG Volume (30 Days)
560.3K
1.3M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
1.04%
1.13%
EPS Growth
15.10
N/A
EPS
3.41
N/A
Revenue
$5,844,600,000.00
N/A
Revenue This Year
$10.41
$10.60
Revenue Next Year
$5.49
$7.41
P/E Ratio
$138.58
$25.61
Revenue Growth
3.84
N/A
52 Week Low
$403.82
$180.27
52 Week High
$565.50
$293.81

Technical Indicators

Market Signals
Indicator
HUBB
RMD
Relative Strength Index (RSI) 43.89 60.88
Support Level $462.95 $198.63
Resistance Level $475.46 $260.21
Average True Range (ATR) 17.05 5.39
MACD -1.33 1.69
Stochastic Oscillator 34.61 89.75

Price Performance

Historical Comparison
HUBB
RMD

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: